Crinetics Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRNX and other ETFs, options, and stocks.

About CRNX

Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly.

CEO

Scott R. Struthers

CEOScott R. Struthers

Employees

437

Employees437

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2008

Founded2008

Employees

437

Employees437

CRNX Key Statistics

Market cap

2.82B

Market cap2.82B

Price-Earnings ratio

-7.84

Price-Earnings ratio-7.84

Dividend yield

—

Dividend yield—

Average volume

828.20K

Average volume828.20K

High today

$30.40

High today$30.40

Low today

$29.83

Low today$29.83

Open price

$30.04

Open price$30.04

Volume

12.96K

Volume12.96K

52 Week high

$62.53

52 Week high$62.53

52 Week low

$24.10

52 Week low$24.10

Analyst ratings

94%

of 17 ratings

Buy

94.1%

Hold

5.9%

Sell

People also own

Based on the portfolios of people who own CRNX. This list is generated using Robinhood data, and it’s not a recommendation.